Translational Genomics Research Institute
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2002-01-01
- Employees
- 501
- Market Cap
- -
- Website
- http://www.tgen.org
A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer
- First Posted Date
- 2017-11-06
- Last Posted Date
- 2022-12-27
- Lead Sponsor
- Translational Genomics Research Institute
- Target Recruit Count
- 24
- Registration Number
- NCT03331562
- Locations
- 🇺🇸
City of Hope National Medical Center, Duarte, California, United States
🇺🇸HonorHealth Research Institute, Scottsdale, Arizona, United States
🇺🇸The University of Kansas Cancer Center, Westwood, Kansas, United States
Studies in Patients With Tuberous Sclerosis Complex
Completed
- Conditions
- First Posted Date
- 2017-09-08
- Last Posted Date
- 2023-11-29
- Lead Sponsor
- Translational Genomics Research Institute
- Target Recruit Count
- 32
- Registration Number
- NCT03276195
- Locations
- 🇺🇸
Translational Genomics Research Institute (TGen), Phoenix, Arizona, United States
Study of Capecitabine and Cetuximab as First-Line Therapy in Patients With Metastatic Wild Type Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Colorectal Cancer
Phase 2
Withdrawn
- Conditions
- First Posted Date
- 2009-08-07
- Last Posted Date
- 2022-10-20
- Lead Sponsor
- Translational Genomics Research Institute
- Registration Number
- NCT00954876
- Locations
- 🇺🇸
Evergreen Hematology & Oncology, Spokane, Washington, United States
© Copyright 2024. All Rights Reserved by MedPath